Not only was Monday the deadline for players and teams to figure out player and club options, but it was also the deadline for teams to decide whether to extend ...
Myriad Genetics said it is in talks with UnitedHealthcare to ensure that enrollees continue to have access to its GeneSight mental health medication test after the insurer changed its coverage policy.
The company is scheduled to hold its third quarter 2024 earnings conference call after the market closes on Thursday November 7, 2024, and intends to provide additional information regarding its ...
Myriad Genetics stock was down 21%, to $17.30, in midday Friday trading. Shares of the diagnostic-test maker have fallen 34% over the past month. Starting Jan. 1, the UnitedHealth Group unit plans to ...
Out of the 30 companies tracked by 360Dx, 22 saw their share prices decline, seven saw their stock prices increase, and one company’s shares remained essentially flat.
It comes at a time when advanced diagnostic tests to gauge "biological age" are becoming popular among the wealthy and health-conscious. Good balance, muscle strength, and an efficient gait or ...
Korin Miller is a freelance writer specializing in general wellness, sexual health and relationships, shopping, and lifestyle trends, with work appearing in Women’s Health, Self, Prevention ...